Zdrowie i gospodarka · 25/09/2025
FDA Solicits Public Comment on Proposed Collection of Information for Positron Emission Tomography Drugs
The Food and Drug Administration is requesting public comment on its proposed collection of information under current good manufacturing practice regulations for positron emission tomography drug products, a medical imaging modality.